Kimberly Chong

Array ( [id] => 6351345 [patent_doc_number] => 20100249212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'Gene Silencing Using mRNA-cDNA Hybrids' [patent_app_type] => utility [patent_app_number] => 12/629845 [patent_app_country] => US [patent_app_date] => 2009-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12045 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249212.pdf [firstpage_image] =>[orig_patent_app_number] => 12629845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9817726 [patent_doc_number] => 08927511 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-06 [patent_title] => 'Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF' [patent_app_type] => utility [patent_app_number] => 13/132997 [patent_app_country] => US [patent_app_date] => 2009-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 8 [patent_no_of_words] => 23803 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13132997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8158518 [patent_doc_number] => 20120100179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'USE OF MICRORNAS TO CONTROL VIRUS HELPER NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 13/132035 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 22740 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100179.pdf [firstpage_image] =>[orig_patent_app_number] => 13132035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6448755 [patent_doc_number] => 20100280095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'THERAPEUTIC AGENT FOR WOUNDS AND SCREENING METHOD FOR THE SAME' [patent_app_type] => utility [patent_app_number] => 12/613134 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12195 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280095.pdf [firstpage_image] =>[orig_patent_app_number] => 12613134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476076 [patent_doc_number] => 20100284990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Compositions and Methods for Making Therapies Delivered by Viral Vectors Reversible for Safety and Allele-Specificity' [patent_app_type] => utility [patent_app_number] => 12/580996 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10772 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0284/20100284990.pdf [firstpage_image] =>[orig_patent_app_number] => 12580996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4565764 [patent_doc_number] => 07846911 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Oligomeric compounds for the modulation of HIF-1alpha expression' [patent_app_type] => utility [patent_app_number] => 12/580126 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16477 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/846/07846911.pdf [firstpage_image] =>[orig_patent_app_number] => 12580126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712274 [patent_doc_number] => 08093223 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-10 [patent_title] => 'RIP140 regulation of diabetes' [patent_app_type] => utility [patent_app_number] => 12/575981 [patent_app_country] => US [patent_app_date] => 2009-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 16 [patent_no_of_words] => 18810 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/093/08093223.pdf [firstpage_image] =>[orig_patent_app_number] => 12575981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6254929 [patent_doc_number] => 20100028996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'RETROVIRAL VECTORS FOR DELIVERY OF INTERFERING RNA' [patent_app_type] => utility [patent_app_number] => 12/575005 [patent_app_country] => US [patent_app_date] => 2009-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8014 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028996.pdf [firstpage_image] =>[orig_patent_app_number] => 12575005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488075 [patent_doc_number] => 20110251262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'Compositions And Methods For Inhibiting Expression Of An RNA From West Nile Virus' [patent_app_type] => utility [patent_app_number] => 13/122659 [patent_app_country] => US [patent_app_date] => 2009-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20809 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251262.pdf [firstpage_image] =>[orig_patent_app_number] => 13122659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968853 [patent_doc_number] => 08507664 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Oligonucleotidic sequences able to silence the expression of the CYCLIN D1-TROP2 chimera and uses thereof in medical field' [patent_app_type] => utility [patent_app_number] => 13/121137 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 8798 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13121137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6378606 [patent_doc_number] => 20100081705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'METHODS FOR SLOWING FAMILIAL ALS DISEASE PROGRESSION' [patent_app_type] => utility [patent_app_number] => 12/566549 [patent_app_country] => US [patent_app_date] => 2009-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9648 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081705.pdf [firstpage_image] =>[orig_patent_app_number] => 12566549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016957 [patent_doc_number] => 20110224284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'PUTATIVE TUMOR SUPPRESSOR MICRORNA-101 MODULATES THE CANCER EPIGENOME BY REPRESSING THE POLYCOMB GROUP PROTEIN EZH2' [patent_app_type] => utility [patent_app_number] => 13/119699 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11833 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224284.pdf [firstpage_image] =>[orig_patent_app_number] => 13119699 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9345041 [patent_doc_number] => 08664189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => 'RNA interference in skin indications' [patent_app_type] => utility [patent_app_number] => 13/120315 [patent_app_country] => US [patent_app_date] => 2009-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 92 [patent_no_of_words] => 52307 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13120315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228966 [patent_doc_number] => 20100183704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'dsRNA FOR TREATING VIRAL INFECTION' [patent_app_type] => utility [patent_app_number] => 12/562349 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17413 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183704.pdf [firstpage_image] =>[orig_patent_app_number] => 12562349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8163983 [patent_doc_number] => 08173366 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Genetic changes in ATM and ATR/CHEK1 as prognostic indicators in cancer' [patent_app_type] => utility [patent_app_number] => 12/586052 [patent_app_country] => US [patent_app_date] => 2009-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 32193 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173366.pdf [firstpage_image] =>[orig_patent_app_number] => 12586052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6354952 [patent_doc_number] => 20100022413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'siRNA targeting Ras-related nuclear protein RAN' [patent_app_type] => utility [patent_app_number] => 12/584850 [patent_app_country] => US [patent_app_date] => 2009-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 35715 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022413.pdf [firstpage_image] =>[orig_patent_app_number] => 12584850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6426635 [patent_doc_number] => 20100168212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'OLIGOMERS' [patent_app_type] => utility [patent_app_number] => 12/556626 [patent_app_country] => US [patent_app_date] => 2009-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17742 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168212.pdf [firstpage_image] =>[orig_patent_app_number] => 12556626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8339922 [patent_doc_number] => 08241846 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-08-14 [patent_title] => 'Hedgehog pathway modulation and uses thereof for treating, preventing and/or diagnosing cancer' [patent_app_type] => utility [patent_app_number] => 12/555077 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 49 [patent_no_of_words] => 20123 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12555077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6247051 [patent_doc_number] => 20100136547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'Pure miRNA Sample Preparation Method' [patent_app_type] => utility [patent_app_number] => 12/554606 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10556 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136547.pdf [firstpage_image] =>[orig_patent_app_number] => 12554606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495720 [patent_doc_number] => 20100093831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'NUCLEIC ACID COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH' [patent_app_type] => utility [patent_app_number] => 12/552185 [patent_app_country] => US [patent_app_date] => 2009-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 106 [patent_figures_cnt] => 106 [patent_no_of_words] => 42307 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093831.pdf [firstpage_image] =>[orig_patent_app_number] => 12552185 [rel_patent_id] =>[rel_patent_doc_number] =>)